Is Anterix, Inc. overvalued or undervalued?

As of 12 August 2025, the valuation grade for Anterix, Inc. has moved from risky to very attractive, suggesting a significant improvement in its investment appeal. Based on the available metrics, Anterix appears to be undervalued, particularly when considering its Price to Book Value of 3.57 and an EV to Capital Employed ratio of 4.17, which indicate potential for growth despite current losses. Additionally, the peer comparison shows that while Anterix has a P/E ratio of 12.26, Spok Holdings, Inc. has a much higher P/E of 20.56, highlighting a relative undervaluation.
Despite this attractive valuation, Anterix has struggled with returns, showing a YTD decline of 30.06% compared to a 12.22% gain in the S&P 500, and a staggering 44.82% drop over the past year against the S&P 500's 17.14% increase. This stark contrast in performance underscores the potential for recovery and value realization in Anterix, reinforcing its current undervalued status.